Table 1 (abstract O6). Change in HbA1c in mmol/mol at 6 months (with 95% confidence intervals) per standard deviation greater baseline value of predictor. A negative value represents a reduction (improvement) in HbA1c
From: Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium
| Â | a) SGLT-inhibitors | b) DPP4-inhibitors | ||||
|---|---|---|---|---|---|---|
| Â | Baseline HbA1c | eGFR | HDL | Baseline HbA1c | BMI | Triglycerides |
CPRD | -9.5 (-9.8;-9.0) | -1.75 (-2.2;-1.3) | 2.2 (1.5;2.9) | -8.4 (-8.6;-8.2) | 1.0 (0.8;1.1) | 0.9 (0.6;1.1) |
Trials | -5.8 (-6.1;-5.5) | -1 (-1.3;0.7) | 0.6 (0.3;0.8) | -4.7 (-5.5;-3.9) | 0.4 (0.0;0.9) | 0.5 (0.1;1.0) |